MBOT - Microbot Medical Inc Stock Price, Fair Value and News

$0.970.00 (0.00%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

MBOT Price Action

Last 7 days

-3%

Last 30 days

5.4%

Last 90 days

10.2%

Trailing 12 Months

-29.2%

MBOT RSI Chart

MBOT Valuation

Market Cap

16.4M

Price/Earnings (Trailing)

-1.47

Price/Sales (Trailing)

148.22

Price/Free Cashflow

-1.83

MBOT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

MBOT Fundamentals

MBOT Revenue

Revenue (TTM)

114.2K

MBOT Earnings

Earnings (TTM)

-11.2M

Earnings Growth (Yr)

-31.44%

Earnings Growth (Qtr)

-30.43%

MBOT Profitability

Return on Equity

-294.25%

Return on Assets

-215.15%

Free Cashflow Yield

-54.61%

MBOT Investor Care

Shares Dilution (1Y)

44.63%

Diluted EPS (TTM)

-0.78

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2016	119.3K	118.5K	114.2K	0
2015	1.4M	994.0K	555.5K	116.9K
2014	943.5K	684.8K	442.0K	1.0M
2013	1.0M	1.0M	1.1M	1.2M
2012	1.6M	1.7M	1.7M	1.4M
2011	1.4M	1.4M	1.4M	1.2M
2010	0	1.1M	1.3M	1.4M
2009	0	0	0	992.9K

Get all data in R, Python etc through our Historical Stock Data APIs

About Microbot Medical Inc

Microbot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom. It primarily engages in the research, design, and development of next generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company also offers LIBERTY, a robotic system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination. In addition, it provides One & Done Technology, an endovascular robotic system for a range of applications in cardiovascular, peripheral vascular, and neurovascular spaces; and NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. Further, the company offers ViRob, an autonomous crawling micro-robot which can be controlled remotely to navigate and crawl in different natural spaces within the human body, including blood vessels, digestive tract, and respiratory system, as well as artificial spaces, such as shunts, catheters, ports, etc. Additionally, it provides ipCAT, a disposable self-propelled locomotive device that is designed to advance in tubular anatomies. The company also has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is headquartered in Hingham, Massachusetts.

CEO	Mr. Harel Gadot
WEBSITE	https://microbotmedical.com
SECTOR	Healthcare
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	18

Microbot Medical Inc Frequently Asked Questions

What is the ticker symbol for Microbot Medical Inc? What does MBOT stand for in stocks?

MBOT is the stock ticker symbol of Microbot Medical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Microbot Medical Inc (MBOT)?

As of Fri Dec 20 2024, market cap of Microbot Medical Inc is 16.42 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MBOT stock?

You can check MBOT's fair value in chart for subscribers.

Is Microbot Medical Inc a good stock to buy?

The fair value guage provides a quick view whether MBOT is over valued or under valued. Whether Microbot Medical Inc is cheap or expensive depends on the assumptions which impact Microbot Medical Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MBOT.

What is Microbot Medical Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, MBOT's PE ratio (Price to Earnings) is -1.47 and Price to Sales (PS) ratio is 148.22. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MBOT PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Microbot Medical Inc's stock?

In the past 10 years, Microbot Medical Inc has provided -0.517 (multiply by 100 for percentage) rate of return.